The Joint (JYNT)
(Delayed Data from NSDQ)
$12.08 USD
-0.20 (-1.63%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $12.08 0.00 (0.00%) 7:32 PM ET
3-Hold of 5 3
B Value A Growth C Momentum B VGM
The Joint Corp. (JYNT) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$16.00 | $30.00 | $9.00 | 30.29% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for The Joint Corp. comes to $16.00. The forecasts range from a low of $9.00 to a high of $30.00. The average price target represents an increase of 30.29% from the last closing price of $12.28.
Analyst Price Targets (4 )
Broker Rating
The Joint Corp. currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.80 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, three are Strong Buy, representing 60% of all recommendations. A month ago, Strong Buy represented 60%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.80 | 1.80 | 1.80 | 1.80 | 1.80 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
3/8/2024 | B. Riley Securities | Jeffrey W Van Sinderen | Strong Buy | Strong Buy |
11/15/2023 | Lake Street Capital Markets | Brooks G O'Neil | Not Available | Strong Buy |
9/19/2023 | Craig-Hallum | Jeremy Hamblin | Not Available | Hold |
9/14/2023 | Roth Capital Partners | George Kelly | Strong Buy | Strong Buy |
8/11/2023 | Maxim Group | Anthony V Vendetti | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.80 |
ABR (Last week) | 1.80 |
# of Recs in ABR | 5 |
Average Target Price | $16.00 |
LT Growth Rate | NA |
Industry | Medical - HMOs |
Industry Rank by ABR | 170 of 252 |
Current Quarter EPS Est: | -0.03 |